Diamyd Medical AB (DYMDF)
0.73
0.00 (0.00%)
USD |
OTCM |
Aug 25, 16:00
Diamyd Medical Shareholders Equity (Quarterly) : 28.09M for May 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2026 | 28.09M |
| February 28, 2026 | 18.82M |
| November 30, 2025 | 24.56M |
| August 31, 2025 | 29.58M |
| May 31, 2025 | 33.80M |
| February 28, 2025 | 10.39M |
| November 30, 2024 | 14.30M |
| August 31, 2024 | 14.25M |
| May 31, 2024 | 18.58M |
| February 29, 2024 | 17.51M |
| November 30, 2023 | 20.08M |
| August 31, 2023 | 15.47M |
| May 31, 2023 | 12.50M |
| February 28, 2023 | 15.00M |
| November 30, 2022 | 17.01M |
| August 31, 2022 | 20.16M |
| May 31, 2022 | 27.39M |
| February 28, 2022 | 30.19M |
| November 30, 2021 | 32.36M |
| August 31, 2021 | 21.91M |
| May 31, 2021 | 26.12M |
| February 28, 2021 | 22.91M |
| November 30, 2020 | 20.75M |
| August 31, 2020 | 8.405M |
| May 31, 2020 | 9.128M |
| Date | Value |
|---|---|
| February 29, 2020 | 9.605M |
| November 30, 2019 | 5.85M |
| August 31, 2019 | 6.402M |
| May 31, 2019 | 7.623M |
| February 28, 2019 | 8.714M |
| November 30, 2018 | 3.778M |
| August 31, 2018 | 4.708M |
| May 31, 2018 | 6.131M |
| February 28, 2018 | 8.051M |
| November 30, 2017 | 9.107M |
| August 31, 2017 | 10.89M |
| May 31, 2017 | 0.9089M |
| February 28, 2017 | 2.055M |
| November 30, 2016 | 2.70M |
| August 31, 2016 | 3.412M |
| May 31, 2016 | 4.077M |
| February 29, 2016 | 3.541M |
| November 30, 2015 | 4.039M |
| August 31, 2015 | 4.658M |
| May 31, 2015 | 4.969M |
| February 28, 2015 | 4.111M |
| November 30, 2014 | 5.155M |
| August 31, 2014 | 6.335M |
| May 31, 2014 | 7.099M |
| February 28, 2014 | 7.961M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Hansa Biopharma AB | -53.75M |
| BioArctic AB | 230.74M |
| Swedish Orphan Biovitrum AB | 4.367B |
| BONESUPPORT HOLDING AB | 98.12M |
| BioInvent International AB | 46.09M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 44.04M |
| Total Liabilities (Quarterly) | 15.95M |
| Debt to Equity Ratio | 0.2051 |
| Current Ratio | 15.50 |
| Net Debt Paydown Yield | -0.31% |